Document is current
Any future updates will be listed below
-
Authors
Xu, Yuanji
Lin, Chuyan
Han, Chun
Wang, Xin
Zhao, Yidian
Pang, Qingsong
Sun, Xinchen
Li, Gaofeng
Zhang, Kaixian
Li, Ling
Qiao, Xueying
Lin, Yu
Xiao, Zefen
Chen, Junqiang
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82373101)
Fujian Natural Science Foundation of Fujian Province (2023J011239)
Fujian Cancer Hospital High-level Personnel Project, China (2022YNG-11)
Fujian Clinical Research Center for Radiation and Therapy of Digestive, Respiratory and Genitourinary Malignancies (2021Y2014, 2021Y2014)
National Clinical Key Specialty Construction Program
- License Information
-
More Information
Article History
Received: 13 September 2024
Accepted: 31 December 2024
First Online: 8 January 2025
Declarations
:
: We formally confirm that all experiments were strictly conducted in accordance with the relevant guiding principles and regulations. This restrospective study was approved by the Ethics Committee of Fujian Cancer Hospital (Approval No. SQ2019-037-01) and the National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (Approval No. NCC2016-06). All patients provided written informed consent prior to treatment, and all information was anonymized prior to analysis.
: Not applicable.
: The authors declare no competing interests.
